The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Summer Symposium 2017

A leader in Convergence, MIT’s Koch Institute for Integrative Cancer Research will, on June 16, present its 16th annual Summer Symposium: the Convergence of Science and Engineering in Cancer Research. Convergence—the merging of historically distinct disciplines such as engineering, physics, computer science, chemistry, mathematics, and the life sciences—has created extraordinary opportunities in cancer research and care. Leaders in this emerging field will discuss innovative new approaches and technologies to better detect, monitor, treat, and prevent cancer. The symposium will also feature a panel of experts to discuss the impact of Convergence on the future of medical care. Register here.


INTRODUCTORY REMARKS

Tyler Jacks

Tyler Jacks, PhD
Director, Koch Institute, MIT
David H. Koch Professor of Biology, MIT

 

Phillip A. Sharp

 

Phillip A. Sharp, PhD
Institute Professor, MIT
Koch Institute, MIT

 

KEYNOTE SPEAKER

Eric Lander

30 Years of Convergence

Eric Lander, PhD
President and Founding Director, Broad Institute of Harvard and MIT
Professor of Biology, Department of Biology, MIT
Koch Institute, MIT
Professor of Systems Biology, Harvard Medical School

 

SPEAKERS

James Collins

Synthetic biology and next-generation diagnostics

James Collins, PhD
Termeer Professor of Medical Engineering and Science and Professor of Biological Engineering, MIT
Broad Institute of Harvard and MIT
Wyss Institute

 

Gad Getz

Cancer Genome and the Cloud

Gad Getz, PhD
Director, Cancer Genome Computational Analysis Group, Broad Institute of Harvard and MIT

 

Paula Hammond

Targeting Aggressive Cancers Nanolayers at a Time: A Platform Approach to Engineered Nanomedicine

Paula T. Hammond, PhD
David H. Koch Professor in Engineering, MIT
Head of the Department of Chemical Engineering, MIT
Koch Institute, MIT

 

Robert Langer

New chemical engineering approaches to convergence

Robert S. Langer, ScD
David H. Koch Institute Professor, MIT
Koch Institute, MIT

 

Daniel Larson

Understanding transcription and splicing heterogeneity in cancer progression

Daniel Larson, PhD
NIH Stadtman Investigator, Center for Cancer Research
Head, Systems Biology of Gene Expression, National Cancer Institute

 

Franziska Michor

Computational Models of Cancer

Franziska Michor, PhD
Professor of Computational Biology, Dana-Farber Cancer Institute
Harvard T.H. Chan School of Public Health

 

Chad A. Mirkin

Spherical Nucleic Acids as a Powerful New Platform for Cancer Therapy

Chad A. Mirkin, PhD
Director, International Institute for Nanotechnology
George B. Rathmann Professor of Chemistry, Department of Chemistry, Northwestern University

 

Aviv Regev

Dissecting the tumor ecosystem with single cell genomics

Aviv Regev, PhD
Core Institute Member, Chair of the Faculty, Broad Institute of Harvard and MIT
Co-director of the Cell Circuits Program, Broad Institute of Harvard and MIT
Koch Institute, MIT

 

Xiaowei Zhuang

Illuminating biology at the nanoscale and systems scale using single-molecule and super-resolution imaging

Xiaowei Zhuang, PhD
David B. Arnold Professor of Science, Harvard University
Howard Hughes Medical Institute Investigator

 

EXPERT PANEL: CONVERGENCE IN HEALTH

Cori Bargmann

 

Cori Bargmann, PhD
President of Science, Chan Zuckerberg Initiative
Torsten N. Wiesel Professor, The Rockefeller University

 

Marc N. Casper

 

Marc N. Casper, MBA
President and CEO, Thermo Fisher Scientific

 

Victor Dzau

 

Victor Dzau, MD
President, National Academy of Medicine

 

Tyler Jacks

 

Tyler Jacks, PhD
Director, Koch Institute, MIT
David H. Koch Professor of Biology, MIT

 

Nancy Simonian

 

Nancy Simonian, MD
CEO, Syros Pharmaceuticals, Inc.

 

Elias Zerhouni

 

Elias Zerhouni, MD
President for Global Research and Development, Sanofi
Former Director, NIH

 

Susan Hockfield

Moderated by:

Susan Hockfield, PhD
President Emerita, MIT
Professor of Neuroscience, MIT
Koch Institute, MIT

 

Supporters

Affiliates

Janssen Research & Development, LLC
Thermo Fisher Scientific

Collaborators

Agilent Technologies
Bayer HealthCare, LLC
Sanofi

Patrons

BioPharma Executive Council
Cell Signaling Technology, Inc.

Friends

Genentech, Inc.
IOP Publishing
Moloquant, Inc.
New England Biolabs

Vendors

Agilent
BioLegend
Cell Signaling Technology, Inc.
Millipore Sigma
Qiagen
Taconic
TCI America
Transnetyx Inc.

Register here.

Event Information

Register here. 

 

To inquire about sponsorship opportunities, please contact us.